We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanoparticles, Magnetic Current, Used to Destroy Head, Neck Tumors

By LabMedica International staff writers
Posted on 01 Apr 2012
Using nanoparticles and alternating magnetic fields, scientists have discovered that head and neck cancerous cells in lab mice can be killed in 30 minutes without injuring healthy cells. More...


The findings, published February 2012 in the journal Theranostics, designates the first time to the researchers’ knowledge this cancer type has been treated using magnetic iron oxide nanoparticle-induced hyperthermia, or above-normal body temperatures, in laboratory mice.

“We show that we can use a small concentration of nanoparticles to kill the cancer cells,” remarked Dr. Qun Zhao, lead author and assistant professor of physics at the University of Georgia’s (Athens, USA) Franklin College of Arts and Sciences. Researchers found that the treatment easily destroyed the cells of cancerous tumors that were composed entirely of a type of tissue that covers the surface of a body, which is also known as epithelium.

Several researchers worldwide are exploring the use of heated nanoparticles as a potential cancer treatment. Earlier research also has revealed that high temperatures created by incorporating magnetic iron oxide nanoparticles with strong alternating magnetic currents can create enough heat to kill tumor cells. Dr. Zhao reported that he is hopeful about his findings, but explained that future studies will need to include larger animals before a human clinical trial could be considered.

For the research, the scientists injected 0.5 mL of nanoparticle solution directly into the tumor site. With the mouse relaxed under anesthesia, they positioned the animal in a plastic tube wrapped with a wire coil that generated magnetic fields that alternated directions 100,000 times each second. The magnetic fields generated by the wire coil heated only the concentrated nanoparticles within the tumor and left the neighboring healthy cells and tissue unharmed.

According to Dr. Zhao, the study creates an avenue for further investigation that might assess how to use a biodegradable nanoparticle material similar to magnetic iron oxide for other roles in fighting cancer, such as carrying and delivering anticancer drugs to the tumor site. “When the cancer cell is experiencing this heated environment, then it becomes more susceptible to drugs,” Dr. Zhao said.

Magnetic iron oxide nanoparticles could be useful in improving the contrast in magnetic resonance imaging (MRI) at a cancer site, he said. Meaning, the nanoparticles could help physicians identify cancer even if it is not visible to the naked eye with an MRI scan. “The reason I am interested in using these magnetic nanoparticles is because we hope to one day be able to offer diagnosis and therapeutics, or theranostics, using a single agent,” Dr. Zhao concluded.

Related Links:
University of Georgia


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Pipette
Accumax Smart Series
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Genai-based pathological assessment workflow for lung adenocarcinoma (Shen J. et al., Int J Surg 111(7): 4252–4262; 2025)

Generative AI Demonstrates Expert-Level Pathological Assessment of Lung Cancer

Lung adenocarcinoma is one of the most difficult cancers to diagnose accurately, requiring pathologists to spend extensive time examining tissue samples under microscopes to determine tumor grades and... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.